Literature DB >> 20543198

Evaluation of non-synonymous NPPA single nucleotide polymorphisms in atrial fibrillation.

Jason D Roberts1, Robert W Davies, Steven A Lubitz, Isabelle L Thibodeau, Pablo B Nery, David H Birnie, Emelia J Benjamin, Robert Lemery, Patrick T Ellinor, Michael H Gollob.   

Abstract

AIMS: Atrial fibrillation (AF), the most common sustained cardiac arrhythmia, is an important cause of morbidity and mortality. A genetic mutation in the NPPA gene, which encodes the atrial natriuretic peptide, has been identified as the putative causative factor in a family with an autosomal dominant pattern of inheritance for AF. Two common single nucleotide polymorphisms (SNPs) in NPPA, rs5063 and rs5065, result in amino acid changes of the primary peptide and have been previously implicated in conditions associated with AF, including stroke and hypertension. Recently, the rs5063 SNP has been reported to confer an increased risk of AF development in a Chinese population. We sought to examine the associations of both rs5063 and rs5065 with AF in two separate North American cohorts of European ancestry. METHODS AND
RESULTS: Patients with early-onset AF, along with healthy controls, were recruited at the University of Ottawa Heart Institute (UOHI) and the Massachusetts General Hospital (MGH). Study participants were genotyped for rs5063 and rs5065 using a combination of restriction fragment length polymorphism analysis and DNA microarrays. The study genotyped a total of 620 AF cases and 2446 healthy controls. The UOHI arm of the study identified an odds ratio (OR) of 0.72 [95% confidence interval (CI): 0.42-1.24] for rs5063, whereas an OR of 1.33 (95% CI: 0.80-2.21) was observed in the MGH arm. The combined OR approximated unity (OR 0.99; 95% CI: 0.54-1.80). Analysis of rs5065 revealed an OR of 1.12 (95% CI: 0.84-1.48) in UOHI, 1.08 (95% CI 0.80-1.45) in MGH, and 1.10 (95% CI 0.90-1.35) when combined.
CONCLUSION: Common non-synonymous genetic variants within NPPA in these two large North American cohorts of European ancestry are not associated with the development of AF.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20543198      PMCID: PMC2910603          DOI: 10.1093/europace/euq161

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  40 in total

Review 1.  Impact of genetic discoveries on the classification of lone atrial fibrillation.

Authors:  Jason D Roberts; Michael H Gollob
Journal:  J Am Coll Cardiol       Date:  2010-02-23       Impact factor: 24.094

2.  Somatic mutations in the connexin 40 gene (GJA5) in atrial fibrillation.

Authors:  Michael H Gollob; Douglas L Jones; Andrew D Krahn; Lynne Danis; Xiang-Qun Gong; Qing Shao; Xiaoqin Liu; John P Veinot; Anthony S L Tang; Alexandre F R Stewart; Frederique Tesson; George J Klein; Raymond Yee; Allan C Skanes; Gerard M Guiraudon; Lisa Ebihara; Donglin Bai
Journal:  N Engl J Med       Date:  2006-06-22       Impact factor: 91.245

3.  Epidemiological approaches to heart disease: the Framingham Study.

Authors:  T R DAWBER; G F MEADORS; F E MOORE
Journal:  Am J Public Health Nations Health       Date:  1951-03

4.  Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence.

Authors:  Yoko Miyasaka; Marion E Barnes; Bernard J Gersh; Stephen S Cha; Kent R Bailey; Walter P Abhayaratna; James B Seward; Teresa S M Tsang
Journal:  Circulation       Date:  2006-07-03       Impact factor: 29.690

5.  The Third Generation Cohort of the National Heart, Lung, and Blood Institute's Framingham Heart Study: design, recruitment, and initial examination.

Authors:  Greta Lee Splansky; Diane Corey; Qiong Yang; Larry D Atwood; L Adrienne Cupples; Emelia J Benjamin; Ralph B D'Agostino; Caroline S Fox; Martin G Larson; Joanne M Murabito; Christopher J O'Donnell; Ramachandran S Vasan; Philip A Wolf; Daniel Levy
Journal:  Am J Epidemiol       Date:  2007-03-19       Impact factor: 4.897

6.  Familial aggregation in lone atrial fibrillation.

Authors:  Patrick T Ellinor; Danita M Yoerger; Jeremy N Ruskin; Calum A MacRae
Journal:  Hum Genet       Date:  2005-11-15       Impact factor: 4.132

7.  A Kir2.1 gain-of-function mutation underlies familial atrial fibrillation.

Authors:  Min Xia; Qingfeng Jin; Saïd Bendahhou; Yusong He; Marie-Madeleine Larroque; Yiping Chen; Qinshu Zhou; Yiqing Yang; Yi Liu; Ban Liu; Qian Zhu; Yanting Zhou; Jie Lin; Bo Liang; Li Li; Xiongjian Dong; Zhiwen Pan; Rongrong Wang; Haiying Wan; Weiqin Qiu; Wenyuan Xu; Petra Eurlings; Jacques Barhanin; Yihan Chen
Journal:  Biochem Biophys Res Commun       Date:  2005-07-15       Impact factor: 3.575

8.  Familial aggregation of atrial fibrillation in Iceland.

Authors:  David O Arnar; Sverrir Thorvaldsson; Teri A Manolio; Gudmundur Thorgeirsson; Kristleifur Kristjansson; Hakon Hakonarson; Kari Stefansson
Journal:  Eur Heart J       Date:  2006-01-20       Impact factor: 29.983

9.  Common variants in KCNN3 are associated with lone atrial fibrillation.

Authors:  Patrick T Ellinor; Kathryn L Lunetta; Nicole L Glazer; Arne Pfeufer; Alvaro Alonso; Mina K Chung; Moritz F Sinner; Paul I W de Bakker; Martina Mueller; Steven A Lubitz; Ervin Fox; Dawood Darbar; Nicholas L Smith; Jonathan D Smith; Renate B Schnabel; Elsayed Z Soliman; Kenneth M Rice; David R Van Wagoner; Britt-M Beckmann; Charlotte van Noord; Ke Wang; Georg B Ehret; Jerome I Rotter; Stanley L Hazen; Gerhard Steinbeck; Albert V Smith; Lenore J Launer; Tamara B Harris; Seiko Makino; Mari Nelis; David J Milan; Siegfried Perz; Tõnu Esko; Anna Köttgen; Susanne Moebus; Christopher Newton-Cheh; Man Li; Stefan Möhlenkamp; Thomas J Wang; W H Linda Kao; Ramachandran S Vasan; Markus M Nöthen; Calum A MacRae; Bruno H Ch Stricker; Albert Hofman; André G Uitterlinden; Daniel Levy; Eric Boerwinkle; Andres Metspalu; Eric J Topol; Aravinda Chakravarti; Vilmundur Gudnason; Bruce M Psaty; Dan M Roden; Thomas Meitinger; H-Erich Wichmann; Jacqueline C M Witteman; John Barnard; Dan E Arking; Emelia J Benjamin; Susan R Heckbert; Stefan Kääb
Journal:  Nat Genet       Date:  2010-02-21       Impact factor: 38.330

10.  The gene encoding atrial natriuretic peptide and the risk of human stroke.

Authors:  S Rubattu; P Ridker; M J Stampfer; M Volpe; C H Hennekens; K Lindpaintner
Journal:  Circulation       Date:  1999-10-19       Impact factor: 29.690

View more
  11 in total

Review 1.  The Role of Pharmacogenetics in Atrial Fibrillation Therapeutics: Is Personalized Therapy in Sight?

Authors:  Dawood Darbar
Journal:  J Cardiovasc Pharmacol       Date:  2016-01       Impact factor: 3.105

Review 2.  2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design.

Authors:  Hugh Calkins; Karl Heinz Kuck; Riccardo Cappato; Josep Brugada; A John Camm; Shih-Ann Chen; Harry J G Crijns; Ralph J Damiano; D Wyn Davies; John DiMarco; James Edgerton; Kenneth Ellenbogen; Michael D Ezekowitz; David E Haines; Michel Haissaguerre; Gerhard Hindricks; Yoshito Iesaka; Warren Jackman; Jose Jalife; Pierre Jais; Jonathan Kalman; David Keane; Young-Hoon Kim; Paulus Kirchhof; George Klein; Hans Kottkamp; Koichiro Kumagai; Bruce D Lindsay; Moussa Mansour; Francis E Marchlinski; Patrick M McCarthy; J Lluis Mont; Fred Morady; Koonlawee Nademanee; Hiroshi Nakagawa; Andrea Natale; Stanley Nattel; Douglas L Packer; Carlo Pappone; Eric Prystowsky; Antonio Raviele; Vivek Reddy; Jeremy N Ruskin; Richard J Shemin; Hsuan-Ming Tsao; David Wilber
Journal:  J Interv Card Electrophysiol       Date:  2012-03       Impact factor: 1.900

Review 3.  Genetics of hypertension and cardiovascular disease and their interconnected pathways: lessons from large studies.

Authors:  Aldi T Kraja; Steven C Hunt; D C Rao; Victor G Dávila-Román; Donna K Arnett; Michael A Province
Journal:  Curr Hypertens Rep       Date:  2011-02       Impact factor: 5.369

Review 4.  A contemporary review on the genetic basis of atrial fibrillation.

Authors:  Jason D Roberts; Michael H Gollob
Journal:  Methodist Debakey Cardiovasc J       Date:  2014 Jan-Mar

Review 5.  Genomics of Atrial Fibrillation.

Authors:  Alejandra Gutierrez; Mina K Chung
Journal:  Curr Cardiol Rep       Date:  2016-06       Impact factor: 2.931

Review 6.  Genetic mechanisms of atrial fibrillation: impact on response to treatment.

Authors:  Dawood Darbar; Dan M Roden
Journal:  Nat Rev Cardiol       Date:  2013-04-16       Impact factor: 32.419

7.  TBX5 mutations contribute to early-onset atrial fibrillation in Chinese and Caucasians.

Authors:  Ji-Fang Ma; Fan Yang; Saagar N Mahida; Ling Zhao; Xiaomin Chen; Michael L Zhang; Zhijun Sun; Yan Yao; Yi-Xin Zhang; Gu-Yan Zheng; Jie Dong; Ming-Jun Feng; Rui Zhang; Jian Sun; Shuo Li; Qun-Shan Wang; Huiqing Cao; Emelia J Benjamin; Patrick T Ellinor; Yi-Gang Li; Xiao-Li Tian
Journal:  Cardiovasc Res       Date:  2016-01-13       Impact factor: 10.787

8.  The human cardiac and skeletal muscle proteomes defined by transcriptomics and antibody-based profiling.

Authors:  Cecilia Lindskog; Jerker Linné; Linn Fagerberg; Björn M Hallström; Carl Johan Sundberg; Malene Lindholm; Mikael Huss; Caroline Kampf; Howard Choi; David A Liem; Peipei Ping; Leif Väremo; Adil Mardinoglu; Jens Nielsen; Erik Larsson; Fredrik Pontén; Mathias Uhlén
Journal:  BMC Genomics       Date:  2015-06-25       Impact factor: 3.969

9.  Atrial natriuretic Peptide single nucleotide polymorphisms in patients with nonfamilial structural atrial fibrillation.

Authors:  Pietro Francia; Agnese Ricotta; Alessandra Frattari; Rosita Stanzione; Anna Modestino; Federico Mercanti; Carmen Adduci; Isabella Sensini; Maria Cotugno; Cristina Balla; Speranza Rubattu; Massimo Volpe
Journal:  Clin Med Insights Cardiol       Date:  2013-09-15

Review 10.  Improved understanding of the pathophysiology of atrial fibrillation through the lens of discrete pathological pathways.

Authors:  Muhammad A Balouch; Matthew J Kolek; Dawood Darbar
Journal:  Glob Cardiol Sci Pract       Date:  2014-01-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.